Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s41232-020-00131-w http://scihub22266oqcxt.onion/10.1186/s41232-020-00131-w 32834892!7406680!32834892     free     free     free       Inflamm+Regen 2020 ; 40 (ä): 19 Nephropedia Template TP {{tp|p=32834892|t=2020. Macrophage activation syndrome and COVID-19 |pdf=|usr=}}{{32834892}} gab.com Text Macrophage activation syndrome and COVID-19 JO: Inflamm Regen http://www.kidney.de/pget.php?&tw=1&pmid=32834892 #FOAvip An emerging, rapidly spreading coronavirus SARS-CoV-2 is causing a devastating pandemic. As we have not developed curative medicine and effective vaccine, the end of this life-threatening infectious disease is still unclear. Severe COVID-19 is often associated with hypercytokinemia, which is typically found in macrophage activation syndrome. SARS-CoV-2 infection causes this strong inflammation within the lung and propagates to respiratory and, ultimately, systemic organ malfunction. Although we have not fully understood the physiological and pathological aspects of COVID-19, current research progress indicates the effectiveness of anti-cytokine therapy. Here, we summarize macrophage activation syndrome and its possible contribution to COVID-19, and cytokine targeted attempts in severe COVID-19 cases. Twit Text FOAVip Macrophage activation syndrome and COVID-19 ????Inflamm Regen http://www.kidney.de/pget.php?&tw=1&pmid=32834892 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32834892 #FOAvip English Wikipedia <ref>{{Cite pmid|32834892}}</ref> Macrophage activation syndrome and COVID-19 #MMPMID32834892 Otsuka R; Seino KI Inflamm Regen 2020[]; 40 (ä): 19 PMID32834892show ga An emerging, rapidly spreading coronavirus SARS-CoV-2 is causing a devastating pandemic. As we have not developed curative medicine and effective vaccine, the end of this life-threatening infectious disease is still unclear. Severe COVID-19 is often associated with hypercytokinemia, which is typically found in macrophage activation syndrome. SARS-CoV-2 infection causes this strong inflammation within the lung and propagates to respiratory and, ultimately, systemic organ malfunction. Although we have not fully understood the physiological and pathological aspects of COVID-19, current research progress indicates the effectiveness of anti-cytokine therapy. Here, we summarize macrophage activation syndrome and its possible contribution to COVID-19, and cytokine targeted attempts in severe COVID-19 cases. äMacrophage activation syndrome and COVID-19 (epmc).pdf DeepDyve Pubget Overpricing